inactivated enterovirus type 71
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
2
Earliest trial started Jul 1, 2016 (NCT02806531)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
- Human enterovirus 71Immunity, active
Human enterovirus 71 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- enterovirus 71 vaccine
- enterovirus vaccination
- inactivated enterovirus type 71
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02804165 | N/A | Sep 1, 2017 | University of Lyon |
| NCT02889497 | Phase 4 | Sep 1, 2016 | Capital Medical University |
| NCT02806531 | Phase 4 | Jul 1, 2016 | Capital Medical University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 2 | 2 | 1 | 2016 |
| University of Lyon | Academic/Hospital | 1 | 1 | 1 | 2017 |
2 organizations
Page 1 / 1